Know More About This Test

The Activated Partial Thromboplastin Time (APTT) test measures the time taken for blood to clot through the intrinsic and common coagulation pathways. It evaluates the function of several clotting factors produced mainly by the liver and is an essential test for assessing bleeding or clotting disorders.

APTT is also widely used to monitor patients receiving heparin therapy and to investigate unexplained bleeding tendencies or recurrent miscarriages.

Why Is This Test Recommended?

Doctors recommend APTT testing in individuals with abnormal bleeding, prolonged clotting times, suspected coagulation disorders such as hemophilia, liver disease, or when monitoring anticoagulant therapy.

What Do the Results Indicate?

Prolonged APTT may indicate clotting factor deficiencies, liver dysfunction, anticoagulant use, or presence of lupus anticoagulant. Normal values suggest intact intrinsic coagulation pathways.

How Is the Test Performed and Prepared For?

A venous blood sample is collected. No fasting is required. Patients should inform the doctor about blood-thinning medications.

Frequently Asked Questions (FAQs)

Is APTT used for clotting or bleeding?
Both; APTT assesses clotting function to identify bleeding disorders and also helps evaluate thrombotic risk in certain conditions.

Does it monitor heparin therapy?
Yes, APTT is the standard test for monitoring unfractionated heparin therapy, ensuring the dosage is therapeutic and safe.

Can pregnancy affect results?
Mildly; pregnancy can cause slight changes in coagulation factors, though significant abnormalities still require investigation.

Is fasting needed?
No, fasting is not required for APTT testing as it measures clotting function, not metabolic parameters.

Is repeat testing common?
Yes, repeat testing is common for monitoring anticoagulant therapy, tracking treatment response, or confirming initial abnormal results.